Regenxbio RGNX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -94.6%+185pp | -280%+17.1pp | -297.1%-63.9pp | -233.2%-267pp | |
| Net margin | -113.8%+159pp | -272.5%+19.4pp | -292%-43.3pp | -248.7%-276pp | |
| Returns | |||||
| Return on equity | -107%-27.5pp | -79.5%-15.8pp | -63.7%-19.9pp | -43.8%-66.2pp | |
| Return on invested capital | -75.7%-4.0pp | -71.7%-10.8pp | -60.9%-9.3pp | -51.6%-103pp | |
| Efficiency | |||||
| Asset turnover | 0.4×+0.2× | 0.2×0.0× | 0.1×0.0× | 0.1×-0.4× | |
| Liquidity | |||||
| Current ratio | 2.4×-0.3× | 2.7×+0.1× | 2.6×-0.6× | 3.2×-0.8× | |
| Leverage | |||||
| Debt-to-equity | 0.7×+0.4× | 0.3×0.0× | 0.3×+0.1× | 0.2×+0.1× | |
| Per Share | |||||
| Book value per share | $1.99-62.0% | $5.24-26.4% | $7.13-40.4% | $11.96-31.3% | |
| Valuation | |||||
| Market capitalization | $529.38M+24.6% | $382.98M-51.5% | $789.82M-19.6% | $981.9M-29.8% | |
| Price / sales | 6×+3.3× | 4.6×-4.2× | 8.8×0.0× | 8.7×+5.7× | |
| Price / book | 25.1×+23.6× | 1.5×-1.1× | 2.5×+0.6× | 1.9×+0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regenxbio's profit margins?
- Regenxbio (RGNX) runs a 59.7% gross margin and a -292.3% operating margin, with a -330.2% net margin.
- Where do Regenxbio's ratios come from?
- Every ratio is computed from Regenxbio's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
